CAROL KREIDER: Open Payments
NPI 1063924769 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,592 in 94 payments from 27 companies in 2025. Trend: 2023 $204 · 2024 $757 · 2025 $2,592
Food & beverage: $2,541Education: $51
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $342 |
| Novo Nordisk Inc | 17 | $296 |
| Amgen Inc. | 16 | $276 |
| Sequel Med Tech, LLC | 7 | $267 |
| SANOFI-AVENTIS U.S. LLC | 5 | $154 |
| Lilly USA, LLC | 3 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $141 |
| Medtronic, Inc. | 1 | $138 |
| Neurocrine BioSciences, Inc. | 1 | $118 |
| Mannkind Corporation | 4 | $101 |
Products named: DEXCOM G7 GSS (161), TWIIST, EVENITY, TZIELD, Ozempic, Kerendia, MINIMED 780G, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
